PORTRAIT 注册研究:跛行患者的病变解剖水平与健康状况的关联
PORTRAIT 注册研究纳入 1275 例跛行患者,其中 623 例有解剖数据,按病变水平分层后使用 PAQ 评估健康状况。多水平病变患者的 PAQ 评分最低,主髂动脉病变患者随时间改善最显著;股腘动脉和膝下动脉病变介入与药物治疗相比未见显著获益。
要点
- 多水平病变患者 PAQ 评分最低,主髂动脉病变患者随时间改善最显著。
- 股腘动脉或膝下动脉病变介入与药物治疗相比未见显著获益。
- 主髂动脉和多水平病变的介入治疗可能带来最大健康状态获益。
核心结论
- 跛行患者总体健康状况在就诊时按病变水平相似,但孤立性主髂动脉病变患者随时间在生活质量和 PAQ 评分上显著更好。
- 主髂动脉和多水平病变介入(主要为腔内)后健康状态改善更明显,而股腘动脉和膝下动脉病变介入未见显著优于药物治疗的获益。
研究设计与样本
- PORTRAIT 为多中心、国际、前瞻性注册研究,纳入 1275 例 PAD 患者。
- 623 例(48.9%)有解剖数据,分为主髂动脉仅(127 例,20.4%)、股腘动脉仅(221 例,35.5%)、膝下动脉仅(39 例,6.3%)和多水平病变(236 例,37.9%)。
- 使用 PAQ 在基线及 3、6、12 个月收集健康状况信息,采用 t 检验、χ2 检验和线性混合效应模型分析。
主要发现
- 基线 PAQ 汇总评分在各病变组间不同,多水平病变最低(P = .014)。
- 主髂动脉病变患者显著更年轻、更多吸烟、踝肱指数更高(均 P < .05)。
- 3 个月内近四分之一患者接受介入,其中 83% 为腔内介入。
- 重复测量分析显示解剖病变与 PAQ 评分随时间显著相关(P = .016),多水平病变调整后平均 PAQ 汇总评分最低(63.1;95%CI 60.8-65.5),显著低于主髂动脉(68.1;95%CI 64.8-71.4;P = .02)和股腘动脉(68.2;95%CI 65.8-70.6;P = .002),但与膝下动脉(66.2;95%CI 60.5-72.0;P = .32)无显著差异。
关键数值与推荐
- 解剖水平分层:主髂动脉仅、股腘动脉仅、膝下动脉仅、多水平病变。
- PAQ 评分调整变量包括年龄、性别、工作状态、踝肱指数、吸烟、糖尿病史、慢性肾病和国家。
临床怎么用
- 临床医生应考虑对跛行患者的主髂动脉和多水平病变进行介入治疗,因其可能最大程度改善整体健康状态。
- 股腘动脉和膝下动脉病变介入与药物治疗相比未见显著健康状态获益,需进一步研究介入与单纯药物治疗的比较。
局限性
- 仅 48.9% 患者有解剖数据,可能存在选择偏倚。
- 膝下动脉仅病变样本量小(39 例),结果解释需谨慎。
- 需要进一步研究评估介入与单纯药物治疗的比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Peripheral artery disease (PAD) has been shown to affect health status and quality of life; however, the disability associated by specific anatomic level of disease is unknown. We evaluated patients presenting with claudication by anatomic level and used the Peripheral Artery Questionnaire (PAQ), a PAD-specific validated tool, to quantify patients' symptoms, function, treatment satisfaction, and quality of life. METHODS: The Patient-centered Outcomes Related to Treatment Practices in peripheral Arterial disease: Investigating Trajectories (PORTRAIT) registry is a multicenter, international, prospective study of patients with PAD. Anatomic level of PAD was stratified as follows: aortoiliac only, femoral-popliteal only, infrapopliteal only, and multilevel disease. Health status information was collected at baseline and at 3, 6, and 12 months using the PAQ. Student t-test, χ2 test, and linear mixed effects models were examined. RESULTS: Anatomic data were present in 623 (48.9%) of 1275 patients: 127 aortoiliac (20.4%), 221 femoral-popliteal (35.5%), 39 infrapopliteal (6.3%), and 236 multilevel disease (37.9%). Groups were similar by sex and race. Baseline PAQ summary scores differed between lesions, with multilevel disease having the lowest (poorest) estimated PAQ summary score (P = .014). Patients with aortoiliac disease were significantly younger, were more likely to be smokers, and presented with higher ankle-brachial index (all P < .05). Almost one-fourth of patients underwent an intervention by 3 months, 83% of which were endovascular. Repeated-measures analyses demonstrated a significant association between anatomic lesion and PAQ scores over time (P = .016), even after adjustment for age, sex, work status, ankle-brachial index, smoking, history of diabetes and chronic kidney disease, and country. Multilevel disease had the lowest adjusted average PAQ summary score over time (63.1; 95% confidence interval [CI], 60.8-65.5) and was significantly lower than aortoiliac (68.1; 95% CI, 64.8-71.4; P = .02) and femoral-popliteal (68.2; 95% CI, 65.8-70.6; P = .002) but not infrapopliteal (66.2; 95% CI, 60.5-72.0; P = .32). CONCLUSIONS: Overall, patients with claudication had similar health status on presentation by level of disease, yet patients with isolated aortoiliac disease fared significantly better over time with regard to quality of life and PAQ scores. Subset analysis demonstrated that patients undergoing interventions for aortoiliac disease and multilevel disease, which were primarily endovascular procedures, appeared to improve health status more over time compared with femoral-popliteal and infrapopliteal interventions. No significant benefits were found with intervention for femoral-popliteal disease or infrapopliteal disease compared with medical management. Treatment of aortoiliac and multilevel disease for claudication should be considered by clinicians as it may represent the greatest potential benefit for improving overall health status in patients with PAD. Further studies evaluating intervention compared with medical management alone are needed to further evaluate this finding.
引用
- Vogel TR, Braet DJ, Kruse RL, et al. Level of disease and association with health status in patients presenting with claudication from the PORTRAIT registry. J Vasc Surg. 2020. PMID: 32325227. doi:10.1016/j.jvs.2020.03.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。